Much like the year preceding it, our 2022 fiscal year was marked with challenges, innovation, and transition. As the world slowly began to re-open amidst the ongoing impacts of Covid-19, the CDC’s National Center for Health Statistics released data reporting on a record number of more than 100,000 drug overdose deaths in the U.S. throughout 2021. Like so many other entities in the behavioral and medical healthcare fields, Gaudenzia, Inc. contended with Covid-era workforce shortages at a time when more people needed our help than ever before. Despite these challenges, we made tremendous progress in providing the best possible care for our clients.